This page contains exclusive content for the member of the following sections: TTS, CTS. Log in to view.
Presenter: Antonello , Pileggi , Miami, United States
Authors: Dora Berman1,2,3,4, Antonello Pileggi1,2,3,4, R. Damaris Molano1,2,3,4, Carmen Fotino1,2,3,4, Norman M. Kenyon1,2,3,4, Norma S. Kenyon1,2,3,4, Camillo Ricordi1,2,3,4
Dora Berman1,2,3,4, Antonello Pileggi1,2,3,4, R. Damaris Molano1,2,3,4, Carmen Fotino1,2,3,4, Norman M. Kenyon1,2,3,4, Norma S. Kenyon1,2,3,4, Camillo Ricordi1,2,3,4
1Diabetes Research Institute, University of Miami, Miami, FL, United States; 2Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; 3Surgery, Microbiology and Immunology, Biomedical Engineering, University of Miami, Miami, FL USA, FL, United States; 4Medicine, University of Miami Miller School of Medicine, Miami, FL, United States
Transplantation of pancreatic islets is a viable therapeutic option for the treatment of unstable diabetes. Currently, islets are transplanted into the portal venous system through their embolization into the liver sinusoids resulting in loss of a substantial islet mass to inflammation and hypoxia. The need for developing alternative, extra-hepatic implantation sites for islets has been recognized. Implantation of islets into omental pouches is appealing because the omentum is well vascularized and has portal blood drainage.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada